Document is current
Any future updates will be listed below
-
Authors
Laney, Victoria
Hall, Ryan
Yuan, Xueer
Hampson, Emma
Halle, Augusta
Yeung, Grace
Bonk, Kristen-Weber
Apte, Suneel
Winter, Jordan
Keri, Ruth
Lu, Zheng-Rong
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 CA235152)
- License Information
-
More Information
Article History
Received: 14 April 2024
Accepted: 12 August 2024
First Online: 28 August 2024
Declarations
:
: The authors declare the following competing interests:Z-R. L. has patents on MT218 and its use for MRI. Z-R. L. is currently employed by Molecular Theranostics, LLC which produces the contrast agent MT218 and oversees the agent’s clinical trial.
